Preventing Acute Kidney Injury and Improving Outcome in Critically Ill Patients Utilising Risk Prediction Score (PRAIOC-RISKS)
Preventing Acute Kidney Injury and Improving Outcome in Critically Ill Patients Utilising Risk Prediction Score - a Pilot Feasibility Randomized Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Background and rationale AKI is common in the intensive care unit .It contributes significantly to mortality and morbidity .the estimated incidence or AKI among critically ill patients is 30-40% and morality is high.
There is a well recognized gap between the optimal care and the delivered care regarding prevention and management of AKI.
The focus over the last few years has been on early detection. A panel of urinary biomarkers have proved helpful for early detection of AKI. However the cost and low specificity make no single one of them solely reliable .using a panel of bio-markers increases their specificity.
The concept of electronic alerts has been recently introduced. Some trials have been testing its impact on the outcome of AKI. The benefit of electronic alerts is still uncertain .A meta-analysis is currently underway to synthesize stronger evidence of electronic alerts benefit.
Another evolving area, is the development of risk score to predict AKI and and hence applying timely preventive measures.
KDIGO recommends applying preventive measures to high risk patients. However no study to date has tested risk scores based interventions
Hypothesis:
We will use the recently validated score to predict AKI in ICU patients. We will then apply preventive measures. To patients at risk .To our knowledge this is the first study to apply preventive interventions based on AKI risk score assessment
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Cairo, Egypten
- Cairo University Hospitals
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
All adult patients (≥18 year old) admitted to the intensive care unit and do not fulfill the criteria for the diagnosis of AKI by Kidney Disease Improving Global Outcome (KDIGO) definition
Exclusion Criteria:
- Patients who have already developed AKI at the time of intensive care unit ICU admission.
- Patients with insufficient medical records to obtain previous medical history
- Patients who lack mental capacity
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Observational
patients will be recruited to this arm to observe prospectively the incidence of AKI among critically ill patients.patients
will receive the standard care.No other intervention will be delivered
|
|
|
Aktiv komparator: Interventional
Patients in this arm will be subject to AKI risk score.
This risk score was recently developed and validated in Mayo clinic the intervention will be Measures to prevent AKI among critically ill patients
|
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of AKI
Tidsramme: during 7 days of ICU admission
|
We will compare the incidence rate between the interventional and the observational arm
|
during 7 days of ICU admission
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
30 day mortality
Tidsramme: 30 days
|
all cause mortality during 30 days of ICU admission or within 30 days of developement of AKI
|
30 days
|
|
Time to recovery after development of AKI
Tidsramme: 30 days
|
Time interval between the diagnosis of AKI and recovery of either blood chemistry or oliguria
|
30 days
|
|
Deterioration of AKI stage
Tidsramme: 30 days
|
Transition from initial stage KDIGO stage 1 to either 2 or 3 .Transition from initial stage 2 to 3
|
30 days
|
|
Duration of dialysis dependency
Tidsramme: 30 days
|
time patient remains dialysis-dependant after severe AKI.
|
30 days
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- KA-13050
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kritisk sygdom
-
Unity Health TorontoUkendtUddannelse, Medicin | Critical Care UltralydCanada
-
Unity Health TorontoAfsluttet
-
Nanjing PLA General HospitalAfsluttetCritical Care Patient; Nedre fordøjelseskanal lidelse; | Colon læsioner;
-
Heidelberg UniversityUkendtSedation af cerebrovaskulært ventilerede Critical Care-patienterTyskland
-
National Taiwan University Clinical Trial CenterRekrutteringKardiologi, Critical Care Medicine, Emergency Medical ServiceTaiwan